• Keine Ergebnisse gefunden

ointments containing 400mg and over of camphor per package and risk of unintended oral ingestion Final SPC and PL wording agreed by the PhVWP in July 2010

N/A
N/A
Protected

Academic year: 2022

Aktie "ointments containing 400mg and over of camphor per package and risk of unintended oral ingestion Final SPC and PL wording agreed by the PhVWP in July 2010"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

ointments containing 400mg and over of camphor per package and risk of unintended oral ingestion

Final SPC and PL wording agreed by the PhVWP in July 2010

Doc. Ref.: CMDh/PhVWP/023/2010 July 2010

SUMMARY OF PRODUCT CHARACTERISTICS

4.9. Overdose

Over dosage may result in skin irritation.

Misuse:

Swallowing of the ointment might cause gastrointestinal symptoms like vomiting and diarrhoea. Treatment is symptomatic.

Acute poisoning was observed after significant accidental consumption, with nausea, vomiting, abdominal pain, and headache, vertigo, feeling hot / flushing, convulsions, respiratory depression and coma.

Patients with severe gastrointestinal or neurological symptoms of poisoning should be observed and treated symptomatically. Do not induce vomiting.

PACKAGE LEAFLET

Section 3

In the case of accidental swallowing of <trade name> by a child, it is important to consult a physician without delay who can provide any necessary treatment. Do not try to induce vomiting.

Camphor July 2010 Page 1/1`

Referenzen

ÄHNLICHE DOKUMENTE

Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such

In an epidemiological study using a UK database, the risk of VTE in association with tibolone was lower than the risk associated with conventional HRT, but only a small proportion

Oral Methotrexate – Review on potential fatal January 2012 Page 1/1 overdose due to medication errors.. Oral Methotrexate – Review on potential fatal overdose due to medication

There have been reports of decreased bone mineral density, osteopenia, osteoporosis and fractures in patients on long-term therapy with [drug name]. The mechanism by which [drug

Acne fulminans, acne aggravated (acne flare), erythema (facial), exanthema, hair disorders, hirsutism, nail dystrophy, paronychia, photosensitivity reaction, pyogenic granuloma,

Section 4.5 Interaction with other medicinal products and other forms of interaction Decreases in blood levels of valproic acid have been reported when it is co-administered

Some cases of severe liver reactions, including cases with fatal outcome or requiring liver transplant, have been reported in both children and adults treated with

The occurrence of (multiple) meningiomas has been reported in association with longer term use (years) of cyproteronacetate at doses of 25mg/day and above. If a patient treated